When endothelial cells malfunction, they can play a part in a host of problems -- including the world's number one cause of death, cardiovascular disease. They also play a role in organ rejection after transplantation. Dr. Jordan Pober's foundational work on endothelial cells holds great promise for new and better therapies. He is director of the Human Translational Immunology Program and vice chair and professsor of immunobiology at Yale.
Information
- Show
- Published18 November 2008 at 19:31 UTC
- Length12 min